Massive teen eczema registry launches to uncover disease patterns

NCT ID NCT06238765

Recruiting now Knowledge-focused Sponsor: CorEvitas Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This observational registry will follow 1,500 adolescents aged 12–15 with moderate-to-severe atopic dermatitis (eczema) across North America and Europe. Researchers aim to document the disease's natural history, how it's managed, and long-term outcomes. Participants will be under the care of a dermatologist and may be on various medications. The study does not test any new drug but hopes to improve understanding of this chronic skin condition in teens.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide a clearer picture of how atopic dermatitis progresses and is managed in adolescents, potentially guiding better treatment approaches.
What could go wrong: As an observational study, it does not test a new treatment, so it won't directly improve outcomes. Results may take years and could be limited by the diversity of the participant group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Show contact details

Locations

CorEvitas, LLC
RECRUITING

Waltham, Massachusetts, 02451, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.